Outcomes of transcutaneous retrobulbar Amphotericin B (TRAMB) as an adjuvant therapy for rhino-orbital-cerebral mucormycosis (ROCM) following COVID-19

被引:4
|
作者
Shakrawal, Jyoti [1 ]
Sharma, Vidhu [2 ]
Goyal, Amit [2 ]
Kumar, Deepak [3 ]
Meena, Seema [1 ]
Tiwari, Sarbesh [4 ]
Jain, Vidhi [5 ]
Elhence, Poonam [6 ]
Soni, Kapil [2 ]
Choudhury, Bikram [2 ]
Bhatnagar, Kavita [1 ]
Garg, Mahendra Kumar [3 ]
Misra, Sanjeev [7 ]
机构
[1] All India Inst Med Sci AIIMS, Dept Ophthalmol, Basni Phase 2, Jodhpur 342005, Rajasthan, India
[2] All India Inst Med Sci AIIMS, Dept Otorhinolaryngol, Basni Phase 2, Jodhpur 342005, Rajasthan, India
[3] All India Inst Med Sci AIIMS, Dept Gen Med, Basni Phase 2, Jodhpur 342005, Rajasthan, India
[4] All India Inst Med Sci AIIMS, Dept Diagnost & Intervent Radiol, Basni Phase 2, Jodhpur 342005, Rajasthan, India
[5] All India Inst Med Sci AIIMS, Dept Microbiol, Basni Phase 2, Jodhpur 342005, Rajasthan, India
[6] All India Inst Med Sci AIIMS, Dept Pathol & Lab Med, Basni Phase 2, Jodhpur 342005, Rajasthan, India
[7] All India Inst Med Sci AIIMS, Dept Surg Oncol, Basni Phase 2, Jodhpur 342005, Rajasthan, India
关键词
COVID-19; Transcutaneous retrobulbar Amphotericin B; Rhino-orbital-cerebral-mucormycosis; MANAGEMENT;
D O I
10.1007/s10792-022-02591-0
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose To assess the outcomes of transcutaneous retrobulbar Amphotericin B (TRAMB) for rhino-orbital-cerebral-mucormycosis (ROCM) post-COVID-19, as an adjuvant to standard systemic antifungal therapy. Methods In this prospective cohort study involving ROCM patients with clinical/radiological orbital involvement, 44 eyes with ROCM stage >= 3B received TRAMB for 7 consecutive days with liposomal Amphotericin-B (3.5 mg/ml) with a minimum clinical and radiological follow-up of 3 months. All patients received standard systemic antifungal therapy also as per institutional protocol. Data pertaining to demography, systemic status, clinical involvement, imaging, surgical/medical management were also recorded. Potential eyes for exenteration were excluded. Please confirm if the author names are presented accurately and in the correct sequence (given name, middle name/initial, family name). Author 12 Given name: [Mahendra Kumar ] Last name [Garg]. Also, kindly confirm the details in the metadata are correct.All author names are presented accurately. Details in the metadata are correct. Thank you. Results Forty-four eyes of 42 patients were included, out of which 30 had diabetes mellitus & 22 had received steroid/oxygen treatment during COVID-19 infection. Forty eyes showed improvement or stable disease on follow-up on radiology. Four eyes which showed progression of the disease in orbit were reaugmented with TRAMB. No patient required exenteration. Subconjunctival haemorrhage occurred in six eyes and temporary blurring of vision in four eyes after TRAMB which resolved spontaneously. Conclusion TRAMB, as an adjuvant to standard systemic antifungal therapy, is associated with a significant reduction or stabilisation of orbital involvement. TRAMB should be considered as an adjuvant therapy for ROCM to reduce disease progression as well as to preserve globe or sight. It has a promising role in preventing potential orbital exenterations.
引用
收藏
页码:1919 / 1926
页数:8
相关论文
共 50 条
  • [41] Survival of a Rhino-Orbital-Cerebral Mucormycosis Patient after Localized Combination Liposomal Amphotericin B Medications: A Case Report
    Zhou, Yang
    CASE REPORTS IN OPHTHALMOLOGY, 2024, 15 (01): : 122 - 128
  • [42] Coronavirus disease (COVID-19) complicated by rhino-orbital-cerebral mucormycosis presenting with neurovascular thrombosis: a case report and review of literature
    Vahid Reza Ostovan
    Shirin Rezapanah
    Zahra Behzadi
    Leila Hosseini
    Reza Jahangiri
    Mohammad Hossein Anbardar
    Mahtab Rostami
    Journal of NeuroVirology, 2021, 27 : 644 - 649
  • [43] Coronavirus disease (COVID-19) complicated by rhino-orbital-cerebral mucormycosis presenting with neurovascular thrombosis: a case report and review of literature
    Ostovan, Vahid Reza
    Rezapanah, Shirin
    Behzadi, Zahra
    Hosseini, Leila
    Jahangiri, Reza
    Anbardar, Mohammad Hossein
    Rostami, Mahtab
    JOURNAL OF NEUROVIROLOGY, 2021, 27 (04) : 644 - 649
  • [44] Secondary infection with rhino-orbital cerebral mucormycosis associated with COVID-19
    Dallalzadeh, Liane O.
    Ozzello, Daniel J.
    Liu, Catherine Y.
    Kikkawa, Don O.
    Korn, Bobby S.
    ORBIT-THE INTERNATIONAL JOURNAL ON ORBITAL DISORDERS-OCULOPLASTIC AND LACRIMAL SURGERY, 2022, 41 (05): : 616 - 619
  • [45] Successful treatment of Rhizopus arrhizus rhino-orbital-cerebral mucormycosis with isavuconazole salvage therapy following extensive debridement
    Miller, R. P.
    Farrugia, L.
    Leask, J.
    Khalsa, K.
    Khanna, N.
    Melia, L.
    MEDICAL MYCOLOGY CASE REPORTS, 2021, 32 : 39 - 42
  • [46] COVID-19-related rhino-orbital-cerebral mucormycosis: Neurological manifestation and related risk factors in two cases
    Ohadi, Mohammad Amin Dabbagh
    Banihashemi, Gelareh
    Dilmaghani, Nader Akbari
    Shamsi, Mohammad Ali
    Sharifi, Guive
    CLINICAL CASE REPORTS, 2022, 10 (10):
  • [47] Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1
    Sen, Mrittika
    Honavar, Santosh G.
    Bansal, Rolika
    Sengupta, Sabyasachi
    Rao, Raksha
    Kim, Usha
    Sharma, Mukesh
    Sachdev, Mahipal
    Grover, Ashok K.
    Surve, Abhidnya
    Budharapu, Abhishek
    Ramadhin, Abhishek K.
    Tripathi, Abhishek Kumar
    Gupta, Adit
    Bhargava, Aditya
    Sahu, Animesh
    Khairnar, Anjali
    Kochar, Anju
    Madhavani, Ankita
    Shrivastava, Ankur K.
    Desai, Anuja K.
    Paul, Anujeet
    Ayyar, Anuradha
    Bhatnagar, Aparna
    Singhal, Aparna
    Nikose, Archana Sunil
    Bhargava, Arun
    Tenagi, Arvind L.
    Kamble, Ashish
    Nariani, Ashiyana
    Patel, Bhavin
    Kashyap, Bibbhuti
    Dhawan, Bodhraj
    Vohra, Busaraben
    Mandke, Charuta
    Thrishulamurthy, Chinmayee
    Sambare, Chitra
    Sarkar, Deepayan
    Mankad, Devanshi Shirishbhai
    Maheshwari, Dhwani
    Lalwani, Dilip
    Kanani, Dipti
    Patel, Diti
    Manjandavida, Fairooz P.
    Godhani, Frenali
    Agarwal, Garima Amol
    Ravulaparthi, Gayatri
    Shilpa, Gondhi Vijay
    Deshpande, Gunjan
    Thakkar, Hansa
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2021, 69 (07) : 1670 - 1692
  • [48] Surgical & medical management of ROCM (Rhino-orbito-cerebral mucormycosis) epidemic in COVID-19 era and its outcomes - a tertiary care center experience
    Soni, Kapil
    Das, Aparna
    Sharma, Vidhu
    Goyal, Amit
    Choudhury, Bikram
    Chugh, Ankita
    Kumar, Deepak
    Yadav, Taruna
    Jain, Vidhi
    Agarwal, Ashwini
    Garg, Mayank
    Bhatnagar, Kavita
    Elhence, Poonam
    Bhatia, Pradeep Kumar
    Garg, Mahendra Kumar
    Misra, Sanjeev
    JOURNAL DE MYCOLOGIE MEDICALE, 2022, 32 (02):
  • [49] COVID-19-Associated Rhino-Orbital-Cerebral Mucormycosis: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis
    Bhattacharyya, Anusuya
    Sarma, Phulen
    Kaur, Hardeep
    Kumar, Subodh
    Bhattacharyya, Jaimini
    Prajapat, Manisha
    Prakash, Ajay
    Sharma, Saurabh
    Reddy, Dibbanti Harikrishna
    Thota, Prasad
    Bansal, Seema
    Gautam, Bhaswati Sharma
    Medhi, Bikash
    INDIAN JOURNAL OF PHARMACOLOGY, 2021, 53 (06) : 499 - 510
  • [50] Rhino-orbital mucormycosis during steroid therapy in COVID-19 patients: A case report
    Veisi, Amirreza
    Bagheri, Abbas
    Eshaghi, Mohammad
    Rikhtehgar, Mohamad Hasan
    Rezaei Kanavi, Mozhgan
    Farjad, Reza
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2022, 32 (04) : NP11 - NP16